Skip to main content
Novartis Top Menu
  • Novartis.com
Novartis Foundation LOGO
    • About Us 
      • Board of Trustees 
        • Joerg Reinhardt, Ph.D. 
        • Ann Aerts, M.D. 
        • Dr. Jo Ivey Boufford 
        • Lutz Hegemann, M.D., Ph.D. 
        • John Kahan 
        • Prof. Peter Piot, M.D. 
      • Our Team 
        • Johannes Boch 
        • Cristina Haffner 
        • Lucy Setian 
        • Sarah Des Rosiers 
        • Xavier Sutter 
      • Our partners 
      About Us
    • Transforming population health 
      • Cardiovascular population health initiative 
      • AI4BetterHearts 
      • Health Policy 
        • Broadband Commission Working Group on Digital and AI in Health 
        • HealthTech Dialogue Hub 
        • AI4HealthyCities Health Equity Network 
      • HealthTech Innovation 
        • Brazil COVID-19 response 
        • AI4Leprosy 
        • HealthTech Hub Africa 
      Transforming Population Health
    • Urban Population Health Toolkit 
      • Quality of care 
      • Ensure access 
      • Policy reform 
      • Leverage data and digital 
      • Intersectoral collaboration 
      • Ensure local ownership 
      Urban Population Health Toolkit
    • Past programs 
      • Better Hearts Better Cities 
        • Community-based Hypertension Improvement Project (ComHIP) 
        • Communities for Healthy Hearts 
        • KaziBantu (Healthy Schools for Healthy Communities) 
      • Leprosy and malaria elimination 
        • The Leprosy Alert and Response Network System (LEARNS) 
        • Leprosy Post-Exposure Prophylaxis (LPEP) program 
        • Malaria Targeted Parasite Elimination Strategy 
      • Digital Health 
        • Ghana Telemedicine 
        • Telemedicine Toolkit 
        • Integrated e-Diagnostic Approach 

      Past Programs - Mega Menu

      Past Programs
    • Media Center 
      • News Archive  
      • Media Library  
      • Stories 
      Media Center
    Homepage
  • Leprosy
    Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
    LeprosyInitiativesPartnershipsGlobal Health
  • Launching AI4BetterHearts, the First Global Data Collaborative for Improving Cardiovascular Health
    Cardiovascular HealthPartnershipsData CollaborativeAIArtificial IntelligenceAnn Aerts
  • Novartis Foundation and Syngenta Foundation Partner to Improve Heart Health through Sustainable Agriculture and Nutrition
    Better Hearts Better CitiesCardiovascular HealthPartnersPartnerships
  • Better Hearts Better Cities
    Strategic progress and policy recommendations to enhance control and management of hypertension and cardiovascular disease in Vietnam
    Better Hearts Better CitiesHypertensionPartnerships
  • About Us, Partners
    Our Partners
    Partnerships are at the center of the Novartis Foundation's population health approach.
    PartnershipsPartners
  • Population Health, Cardiovascular Health
    Better Hearts Better Cities
    This initiative convened multisector partners to improve cardiovascular health in low-income urban populations.
    Cardiovascular HealthBetter Hearts Better CitiesHypertensionPartnerships
  • Population Health, Artificial Intelligence
    Brazil COVID-19 Response
    AI platform in São Paulo, Brazil helps diagnose COVID-19 patients faster
    COVID-19PartnershipsPartners
  • Novartis Foundation Leprosy Program Wins Eyeforpharma Most Valuable Collaboration Award 2019
    Novartis Foundation leprosy program wins eyeforpharma Most Valuable Collaboration Award 2019.
    LeprosyPartnerships

Novartis Foundation

Navigate Novartis Foundation
  • About Us
  • Transforming Population Health
  • Urban Population Health Toolkit
  • Past Programs
About the Novartis Foundation
  • Board of Trustees
  • Our Partners
  • Our Team
Media Center
  • News Archive
  • Media Library
  • Our Stories
Footer Bottom
© 2022 Novartis Foundation
  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for a global audience